24/7 Patient Assistance: 760-405-8205

Robert A. Kratzke, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Robert Kratzke practices as a medical oncologist at the Masonic Cancer Center of University of Minnesota. Dr. Kratzke graduated from the University of Washington School of Medicine in 1983 and moved to the University of Wisconsin Hospital for his residency. Dr. Kratzke followed a fellowship program at the National Cancer Institute in Bethesda between 1988 and 1991. Dr. Robert Kratzke also practices as an associate professor of the hematology, oncology, and transplantation division at the University of Minnesota. A specialist in cancers of the lungs, specifically mesothelioma, Dr. Kratzke studied and researched treatment methods that are being used today to efficiently help patients with this type of cancer.

    Insurance Accepted


  • Education & Training


    University of Washington School of Medicine, Seattle, WA - 1983

    Medical School


    University of Wisconsin Hospital, Madison, WI - 1986



    National Cancer Institute, Bethesda, MD (1988-1991)


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    University of Minnesota Medical Center

    Languages: English/Spanish

    (612) 273-3000

    2450 Riverside Ave

    Minneapolis, Minnesota 55454

    Read More
  • Publications & Memberships

    Dr. Robert A. Kratzke has contributed to 3 publications.

    Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.

    Patel, M. R.,Jacobson, B. A.,Belgum, H.,Raza, A.,Sadiq, A.,Drees, J.,Wang, H.,Jay-Dixon, J.,Etchison, R.,Federspiel, M. J.,Russell, S. J.,Kratzke, R. A.; J Thorac Oncol. 2014 Aug 27

    See more >>

    Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.

    Chen, E. Z.,Jacobson, B. A.,Patel, M. R.,Okon, A. M.,Li, S.,Xiong, K.,Vaidya, A. J.,Bitterman, P. B.,Wagner, C. R.,Kratzke, R. A.; Invest New Drugs. 2014 Apr 09.

    See more >>

    SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.

    Khatri, A.,Williams, B. W.,Fisher, J.,Brundage, R. C.,Gurvich, V. J.,Lis, L. G.,Skubitz, K. M.,Dudek, A. Z.,Greeno, E. W.,Kratzke, R. A.,Lamba, J. K.,Kirstein, M. N.; Br. J. Cancer. 2013 Dec 05.

    See more >>


    American College of Surgeons

    American Federation for Medical Research

    American Society of Clinical Oncology

    Cancer and Leukemia Group B

    Mesothelioma Applied Research Foundation